Adrian Newman-Tancredi
Chief Executive Officer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Adrian Newman-Tancredi is the Chief Executive Officer at Neurolixis. He is based in France and specializes in pharmacological MRI methodologies. His recent research focuses on investigating the functional selectivity of 5-HT1A receptor biased agonists.
Articles (1)
Year:
2020
Collaborators (2)
Jean-Baptiste Langlois
CNRS Délégation Alpes
FRANCE
Luc ZIMMER
Professor of Pharmacology (PU-PH)
Université Claude Bernard Lyon 1
FRANCE
Make your next move.
Prepare your application
Review drafts before you send them.